Helperby - News

On March 9th 2016 Helperby Therapeutic held a pre-IND meeting with the FDA division of Anti-Infective products. The outcome is a road map for the clinical development of a drug product for the treatment of complicated urinary tract infections.

This is an important area of research due to the rapidly emerging multi drug resistance of gram negative infections.